Literature DB >> 32552217

Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning.

Madhoosudan A Patil1, Uday B Kompella1,2,3,4.   

Abstract

Purpose: To determine the baseline choroid-retina fluorescence signal in Royal College of Surgeon (RCS) rats of various ages with different degrees of retinal degeneration and assess the persistence of intravitreal nanoparticles.
Methods: In RCS rats of age 6, 12, and 20 weeks and Sprague Dawley (SD) rats of age 6 and 20 weeks, baseline eye tissue fluorescence and retinal thickness were recorded noninvasively using fluorophotometry and optical coherence tomography (OCT), respectively. Further, 20-nm carboxylate-modified fluorescent particles were injected intravitreally in the above groups of rats, and the depth-wise fluorescence signal was monitored over 7 days using fluorophotometry and confocal laser scanning ophthalmoscopy (cSLO). Additionally, 200 nm particles of the same material were injected intravitreally into about 7-week-old RCS rats and the fluorescence signal was monitored up to 35 days using fluorophotometry.
Results: Reduction in retinal thickness and an increase in choroid-retina and lens baseline fluorescence was observed with increasing age of RCS and SD rats. The 20 nm particles persisted in the vitreous of animals from all age groups for at least 7 days postadministration, irrespective of the differences in retinal thickness. cSLO confirmed nanoparticle persistence in the eye. The fluorescence signal from 200 nm particles persisted for 35 days in the vitreous humor. Conclusions: Choroid-retina and lens autofluorescence monitored using fluorophotometry increase with age. Intravitreally injected nanoparticles can be monitored noninvasively in rats using fluorophotometry and cSLO imaging. Both 20 and 200 nm particles persist in the back of the eye tissues, for several days following intravitreal injection.

Entities:  

Keywords:  fluorophotometry; intravitreal delivery; nanoparticles; noninvasive monitoring; ocular drug delivery

Year:  2020        PMID: 32552217      PMCID: PMC7404824          DOI: 10.1089/jop.2020.0028

Source DB:  PubMed          Journal:  J Ocul Pharmacol Ther        ISSN: 1080-7683            Impact factor:   2.671


  24 in total

1.  Ophthalmic drug delivery systems for the treatment of retinal diseases: basic research to clinical applications.

Authors:  Henry F Edelhauser; Cheryl L Rowe-Rendleman; Michael R Robinson; Daniel G Dawson; Gerald J Chader; Hans E Grossniklaus; Kay D Rittenhouse; Clive G Wilson; David A Weber; Baruch D Kuppermann; Karl G Csaky; Timothy W Olsen; Uday B Kompella; V Michael Holers; Gregory S Hageman; Brian C Gilger; Peter A Campochiaro; Scott M Whitcup; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-11       Impact factor: 4.799

Review 2.  Ocular fluorometry: principles, fluorophores, instrumentation, and clinical applications.

Authors:  F Docchio
Journal:  Lasers Surg Med       Date:  1989       Impact factor: 4.025

3.  Simultaneous optical coherence tomography and lipofuscin autofluorescence imaging of the retina with a single broadband light source at 480nm.

Authors:  Minshan Jiang; Tan Liu; Xiaojing Liu; Shuliang Jiao
Journal:  Biomed Opt Express       Date:  2014-11-12       Impact factor: 3.732

4.  The aging rat retina: from function to anatomy.

Authors:  Francisco M Nadal-Nicolás; Manuel Vidal-Sanz; Marta Agudo-Barriuso
Journal:  Neurobiol Aging       Date:  2017-09-28       Impact factor: 4.673

Review 5.  Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.

Authors:  Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-05       Impact factor: 2.671

6.  Changes in corneal autofluorescence and corneal epithelial barrier function with aging.

Authors:  S W Chang; F R Hu
Journal:  Cornea       Date:  1993-11       Impact factor: 2.651

7.  Dexamethasone - PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation.

Authors:  Burçin Yavuz; Sibel Bozdağ Pehlivan; Burcu Sümer Bolu; Rana Nomak Sanyal; İmran Vural; Nurşen Ünlü
Journal:  J Pharm Pharmacol       Date:  2016-06-10       Impact factor: 3.765

Review 8.  Vitreous fluorophotometry: a review.

Authors:  M F Raines
Journal:  J R Soc Med       Date:  1988-07       Impact factor: 18.000

Review 9.  Retinitis pigmentosa.

Authors:  Christian Hamel
Journal:  Orphanet J Rare Dis       Date:  2006-10-11       Impact factor: 4.123

Review 10.  Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules.

Authors:  Marcella Nebbioso; Alessandro Lambiase; Alberto Cerini; Paolo Giuseppe Limoli; Maurizio La Cava; Antonio Greco
Journal:  Int J Mol Sci       Date:  2019-04-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.